Methylphenidate does not lead to growth restrictions in the longer term. This is the conclusion of a systematic review published in The Lancet Psychiatry (2023; online March 20).
Methylphenidate is the most commonly used drug for ADHD in children and young adults. Its short-term safety has been demonstrated in several randomized…
The entire content of this article is only accessible to subscribers.
Read 3 articles FREE
Make an account. Free and without obligation.
I want 3x free
Always access to all NTvG publications?
Subscribe today!
Take the introductory subscription
€ 32.95 for 12 weeks!
I want to meet
Do you already have a subscription? login
2023-05-26 04:00:00
#growth #restriction #methylphenidate
